LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Analysts
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports...